JPRN-UMIN000007130已完成未知
A multicenter randomized study evaluating the efficacy and safety of HMG-CoA reductase inhibitors (statins) in dyslipidemic patients with nephrosclerosis. - Prospective evaluation of eGFR in CKD with nephrosclerosis by lipid intervention study (LAKE study)
Omihachiman Community Medical Center0 个研究点目标入组 77 人开始时间: 2012年1月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 77
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who are treated with statins 2. Patients who are planned to start or change medication for renal disease 3. Severe hypertensive patients (SBP>=150mmHg or DBP >=90mmHg) 4. Severe hepatic dysfunction 5. Abnormal values of serum creatinine caused by any disease except renal disease 6. BMI>25(kg/m2) 7. Patients with thyroid dysfunction 8. History of acute myocardial infarction or stroke during three months prior to the registration 9. Pregnant, breast feeding, or could be pregnant 10. Patients who do not accept informed consent 11. Patients judged as being inappropriate for this study by investigators
研究者
相似试验
招募中
3 期
A randomized, multicenter study to assess the efficacy on disease activity on enteric-coated mycophenolate sodium (EC-MPS, myfortic) versus continuation of azathioprine in patients with systemic lupus erythematosus on azathioprine maintenance therapy.lupusSLE10021460NL-OMON30478Erasmus MC, Universitair Medisch Centrum Rotterdam48
进行中（未招募）
1 期
A randomized, multi-center study to assess the effect of Darbepoetin alfa (Aranesp®) for the treatment of anemia in patients with advanced hormone independent prostate cancer and anaemia - DANCAPepoIn an open randomised, multi-center study to identify the haematopoietic response to Aranesp® (Darbepoetin 6,75 mcg/kg) administrated every fourth week compared to standard care of treatment in patients with anaemia due to hormone refractory prostate cancer with progression of skeletal metastases. A haematopoietic response is defined as haemoglobin concentration > 12 g/dl or increase in haemoglobin > 2 g/dl during the treatment phase.MedDRA version: 6.1Level: PTClassification code 10038444EUCTR2005-005658-37-DKDpt. of Urology -K. Aarhus University Hospital140
进行中（未招募）
1 期
Trial to evaluate the efficacy of fentanyl pectin nasal spray (FPNS) versus Physician Choice (PC) - Usual Care (UC), in patients with head and neck cancer undergoing radiotherapy.Patients with head and neck cancer .MedDRA version: 21.1Level: PTClassification code 10067821Term: Head and neck cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-005110-30-ITFONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI158
进行中（未招募）
1 期
A multicenter randomized trial to evaluate the efficacy of tocilizumab in patients with severe Coronavirus Disease 2019 (Covid-19) pneumonia failing glucocorticoids.polmonite severa da coronavirus 2019MedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862EUCTR2020-005291-35-ITAOU POLICLINICO DI MODENA640
招募中
1 期
A multicenter randomized trial to evaluate the efficacy of pioglitazone to improve renal outcome in ANCA-associated vasculitis - RENATOANCA-associated vasculitisCTIS2022-501057-36-00Assistance Publique Hopitaux De Paris126